Health ❯ Healthcare ❯ Cancer ❯ Cancer Research

Clinical Trials

Daraxonrasib Nearly Doubles Survival in Pancreatic Cancer Trial

The FDA fast-tracked review to open expanded access for some patients.

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

Morning Immunotherapy Boosts Survival in Lung Cancer Trial

Sir Bobby Robson Foundation Unveils £30 Million Cancer Institute Plan in Newcastle

NHS Begins Phase II/III Trial of mRNA Vaccine for Head and Neck Cancer

FDA Reviews Pembrolizumab for Transformative Head and Neck Cancer Treatment